Search research articles
Contact Us
Filters
Showing results (251-260 of 271) with videos related to
Page
of 28
Sort By:
Iscience
|
January 15, 2025
CD137 agonism enhances anti-PD1 induced activation of expanded CD8<sup>+</sup> T cell clones in a neoadjuvant pancreatic cancer clinical trial
Janelle M Montagne, Jacob T Mitchell, Joseph A Tandurella, et al.
Biorxiv : the Preprint Server for Biology
|
October 31, 2023
Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade
Daniel H Shu, Won Jin Ho, Luciane T Kagohara, et al.
Biorxiv : the Preprint Server for Biology
|
September 25, 2023
Digitize your Biology! Modeling multicellular systems through interpretable cell behavior
Jeanette A I Johnson, Genevieve L Stein-O'Brien, Max Booth, et al.
Cancer Research
|
September 5, 2019
Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma
Mark Yarchoan, Parul Agarwal, Augusto Villanueva, et al.
Science (New York, N.Y.)
|
September 6, 2008
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Siân Jones, Xiaosong Zhang, D Williams Parsons, et al.
JCI Insight
|
June 26, 2025
Spatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasia
Melissa R Lyman, Jacob T Mitchell, Sidharth Raghavan, et al.
Cancer Research
|
April 8, 2024
Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal Adenocarcinoma
Samantha Guinn, Benedict Kinny-Köster, Joseph A Tandurella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2025
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer
Jennifer J Knox, Grainne O'Kane, Daniel King, et al.
Science (New York, N.Y.)
|
June 11, 2021
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade
Sneha Berry, Nicolas A Giraldo, Benjamin F Green, et al.
Nature Communications
|
February 10, 2026
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial
Amanda L Huff, S Daniel Haldar, Alexander A Gergis, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 271) with videos related to
Sort By:
Page
of 28
Iscience
|
January 15, 2025
CD137 agonism enhances anti-PD1 induced activation of expanded CD8<sup>+</sup> T cell clones in a neoadjuvant pancreatic cancer clinical trial
Janelle M Montagne, Jacob T Mitchell, Joseph A Tandurella, et al.
Biorxiv : the Preprint Server for Biology
|
October 31, 2023
Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade
Daniel H Shu, Won Jin Ho, Luciane T Kagohara, et al.
Biorxiv : the Preprint Server for Biology
|
September 25, 2023
Digitize your Biology! Modeling multicellular systems through interpretable cell behavior
Jeanette A I Johnson, Genevieve L Stein-O'Brien, Max Booth, et al.
Cancer Research
|
September 5, 2019
Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma
Mark Yarchoan, Parul Agarwal, Augusto Villanueva, et al.
Science (New York, N.Y.)
|
September 6, 2008
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Siân Jones, Xiaosong Zhang, D Williams Parsons, et al.
JCI Insight
|
June 26, 2025
Spatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasia
Melissa R Lyman, Jacob T Mitchell, Sidharth Raghavan, et al.
Cancer Research
|
April 8, 2024
Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal Adenocarcinoma
Samantha Guinn, Benedict Kinny-Köster, Joseph A Tandurella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2025
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer
Jennifer J Knox, Grainne O'Kane, Daniel King, et al.
Science (New York, N.Y.)
|
June 11, 2021
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade
Sneha Berry, Nicolas A Giraldo, Benjamin F Green, et al.
Nature Communications
|
February 10, 2026
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial
Amanda L Huff, S Daniel Haldar, Alexander A Gergis, et al.
Page
of 28